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Abstract
Objectives
Compare epidemiology, clinical manifestations and outcome of tuberculosis between diabetic
and non-diabetic patients admitted to King Abdulaziz University Hospital in Jeddah, Saudi
Arabia.
Methods
Review the medical data of adult inpatients with tuberculosis from January 2002 to December
2007. Demographic data, location of tuberculosis, sputum positivity for acid fast bacilli,
duration of hospitalization and outcome (relapses, drug resistance and inhospital mortality)
were compared between the two groups.
Results
From total of 216 tuberculosis cases, 35 (16%) had diabetes. These were older in age. 68%
diabetics were over 50 years compared to 16% non-diabetics. (p=O.OOOl). Ratio of Saudis to
non-Saudis with tuberculosis was greater in diabetics than in non-diabetics (p=0.003).
Pulmonary tuberculosis was the most common site affected and was associated with poor
glycemic control (p = 0.013). Smear positivity for acid fast bacilli was not different in diabetics
and non-diabetics (p = 0.66). Outcome was favorable and not significantly different in
diabetic patients (p = 0.096)
Conclusion
Saudi diabetic patients have increased risk of tuberculosis. Pulmonary tuberculosis is most
common in diabetics and is associated with poor glucose control. Diabetes does not alter the
outcome of tuberculosis significantly.
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Introduction
Tuberculosis remains a major globalpublic health problem with a high
morbidity and mortality. Annually 8-10
million new cases and 3 million deaths are
reported 1. A strong association between
diabetes mellitus (DM) and tuberculosis
(TB) is well documented 2. Both these
diseases are major health problems in the
Kingdom of Saudi Arabia, where TB is
considered an endemic disease 3 and the
prevalence of DM is growing rapidly. 4
There is very little data on TB in DM
patients in Saudi Arabia. We conducted this
study to compare the epidemiology and
clinical aspects of TB between diabetic and
non- diabetic patients admitted to King
Abdulaziz University Hospital (KAUH) in
Jeddah, Saudi Arabia.
Materials and Methods
This retrospective study was conducted in
KAUH, Jeddah, which is a tertiary hospital
in the Western region of Saudi Arabia.
Approval of the ethical committee in KAUH
was taken.
The medical records were reviewed for data
collection. Information about demographic
data, location of TB, sputum positivity for
acid fast bacilli (AFB) staining in case of
pulmonary TB (PTB), presence or absence of
DM, blood glucose level on admission and 2
months before, duration of hospital stay,
number of relapses, resistance to
antituberculosis treatment and inhospital
mortality, were recorded.
Inclusion criteria included adult patients
aged 13 years and above who were admitted
during the period of January 2002 to
December 2007 with a discharge diagnosis
ofTB.
Exclusion criteria included patients with
positive HIV result, patients on steroids or
immunosuppressive therapy.
Diagnosis of PTB was based on positive AFB
staining, positive culture for TB bacilli, or
typical radiological findings with high
clinical probability of TBS. For extra
pulmonary TB, the diagnosis was based on
histopathology of tissue specimens';
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Patients were considered to be diabetic if
they had a previous history of DM and were
receiving antidiabetic therapy at the time of
hospital admission or were later found to
have two fasting blood glucose levels
~126mg/dL or random blood glucose level
~200mg/dL in the presence of classical
symptoms of DM. Diabetic patients were
considered controlled if their fasting blood
glucose was <130mg/dL or peak post
prandial blood glucose <180mg/dL
according to the guidelines of the American
Diabetes Association in 2009. Blood tests
were done on admission and 2 months
before admission.
Statistical analysis was performed using
Statistical Package for Social Sciences (SPSS)
version 13.0. Chi-square test was performed
to analyze the categorical variables,
student's t-test was used to analyze
numerical variables for group differences. p-
value of 0.05 or less was considered of
statistical significance.
Results
As shown in Table I, there were total of 216
TB patients admitted in KAUH during the
study period. 35/216 (16%) were diabetic.
TB patients with DM were older than non-
diabetics. 68% TB diabetics were over 50
years of age compared to 16% non-diabetic
patients which was statistically significant
with p=O.OOOI.
TB patients with DM had a higher
men:women ratio than non diabetics. They
had higher Saudi to non-Saudi ratio than
non-diabetics.
Saudi diabetics were 27% (18/66) and were
more than non-Saudi diabetics who were
11% (17/150).
Also Saudi diabetics were more than Saudi
non-diabetics (51% vs 26%). These figures
were significant (p=0.003).
For disease location, the lungs were the
most common site (54% in diabetics and
39% in non-diabetics). In extra pulmonary
TB, bones were the most common site in
diabetics (20% vs. 13%) while lymph nodes
were the predominant site in non-diabetic
patients (17% vs. 3%). This was statistically
significant with p=0.041. As shown in Table
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2, smear positivity for AFB in PTB was 40%
(36/90) and was higher in diabetics than
non-diabetics 42% (8/19) vs. 37% (26/71),
but did not reach statistical significance
(p=0.6)
As shown in Table 3 there was no
significant difference between both groups
regarding the duration of hospital stay
(27±18 days, range 7-75) in TB patients, (30 ±
18 days, range 10-80) in TB DM patients,
with p= 0.138.
Readmission for TB occurred in 11/216 (5%)
patients. Nine had one recurrence (6 of
whom had PTB and 2 were diabetics), two
had 2 recurrences (both had PTB and one
was diabetic).
Multi drug resistance to TB treatment
(MDR-TB) developed in 4/216 (2%) patients.
All had PTB and only one was diabetic. All
improved on second line antituberculosis
therapy.
In-hospital mortality was 3.7% (8/216). All
had PTB and although 9% (3/35) were
diabetic and 3% (5/181) were non-diabetic,
the p-value was not significant (0.096).
Most of the diabetics had high blood glucose
on admission to the hospital, 26/35 (75%). It
was found that these patients had more PTB
than patients with controlled blood sugar
and it was of significant statistical value
(p=0.013) as shown in Table 4.
As shown in Table 5 there was no statistical
significant difference between controlled
and uncontrolled diabetics regarding AFB
positivity (p=0.178). Table 6 shows the
duration of hospital stay which was not
different between the 2 groups, (p=0.55). It
also shows that all the 3 diabetics who had
relapses were uncontrolled still the result
was not significant statistically (p=0.61).
MDR - TB occurred in only 1 diabetic who
had uncontrolled blood glucose and the
result was not significant (p=0.58)
Inhospital mortality occurred in 3 diabetics,
2 had controlled blood glucose but it was in
significant (p=O.65)
Discussion
From the total number of TB patients who
were studied, 16% had coexisting DM. This
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figure is similar to other reported cases from
Turkey, Malaysia, Indonesia and India. 6-9
In Saudi Arabia, it was found that the
prevalence of DM in Saudi population is
23.7%, as reported by Al Nozha et al in
20044 • In our study DM was found in 27% of
our Saudi patients.
This figure is higher than the one reported
by the above-mentioned study, meaning
that the prevalence of DM was found to be
more in TB patients in our study.
The current study showed few differences in
some aspects between DM and non DM
patients who had TB (including PTB).
It showed that as the age increased, more TB
was found in DM patients, a similar finding
reported by others. 7,10,11-13
Moreover it demonstrated that the
percentage of TB in Saudi diabetics was
significantly higher than that in Saudis
without DM (51% vs 26%). This finding is
similar to another study from Saudi Arabia.
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It also showed that the percentage of male
diabetic patients was slightly higher in
comparison to non-diabetic males, which is
supported also by previous studies. 7,11,12
The above findings showed statistical
significance and it is alarming to know that
Saudi diabetics are having higher
prevalence of TB than non-Saudis and non-
diabetic Saudis which shows the positive
association between DM and TB in Saudi
Arabia.
In the present study, PTB was considered
the most common form found in DM
patients, whereas in non-diabetics
extrapulmonary TB was more common. The
increased association of DM with PTB rather
than extrapulmonary TB was also reported
previously 7, indicating that the presence of
DM continues to play an important role in
the development of PTB.
In extrapulmonary TB, bone disease was the
most common form found in DM patients,
whereas lymph node involvement was the
predominant site in non-diabetic patients, as
was the case in another report? The high
rate of involvement of lymph nodes in
extrapulmonary TB in our total TB patients
in comparison to other sites was also seen in
other studies. 14,15
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Table 1: Characteristics of 216 patients with tuberculosis
Range of Age
Meant SD
Age group:
10-19
20-29
30-39
40-49
50-59
60-69
70<
Gender:
Men(M)
Women(W)
M:Wratio
Nationality
Saudi (S)
NonSaudi (NS)
S: NS ratio
Disease location:
Lungs
Lymph nodes
Bones
Pleura
Nervous system
Gastrointestinal system
Reproductive system
Others
13-70 years
29 ± 16 years
45 (25%)
37 (21%)
42 (23%)
27 (15%)
16 (9%)
8 (4%) 16%
6 (3%)
73 (40%)
108 (60%)
1:1.5 (2/3:1)
48 (26%)
133(74%)
1:3 (1/3:1)
71 (39%)
31 (17%)
22 (13%)
18 (10%)
17 (9%)
14 (8%)
4 (2%)
4 (2%)
25-75 years
48 ± 14.6 years
0(0%)
3 (9%)
6 (18%)
2 (5%)
9 (26%
13 (37%) 68%
2 (5%)
18 (51%)
17 (49%)
1:1
18 (51%)
17 (49%)
1:1
19 (54%)
1 (3%)
7 (20%)
1 (3%)
2 (6%)
1 (3%)
0(0%)
4 (11%)
0.0001
0.003
0.041
SD = Standard deviation
TB DM group = Tuberculosis patients with diabetes mellitus
TB group = Tuberculosis patients without diabetes mellitus
Others = breasts, skin, kidneys, heart
Table 2: Smear positivity for AFB in ptb diabetics and non-diabetics
26 (37%)
45 (63%)
p = 0.661
151
8 (42%)
11 (58%)
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Table 3: Comparison between diabetics and non-diabetics according to different variables
Variables
TB Group (181)
No. (%)
TB DM Group (35)
No. (%) p Value
27± 18 days, range 7-75
32 (91%)
34 (97%)
32 (91%)
0.63
0.096
0.138
0.372
-
-
-
-
-
-
-
-
-
-
- •. I: I
.
2 (6%)
3 (9%)
1 (3%)
1 (3%)
: .-
7 (4%)
3 (2%)
5 (3%)
1 (1%)
173 (95%)
176 (97%)
178 (98%)
I
I
I
I
I
I
I
I
I
I
No. of admissions
1
2
3
Duration of hospital stay
MDR-TB
Yes
No
Inhospital mortality
Yes
No
Table 4: Relation of blood glucose to location of tuberculosis in diabetic patients
* = p value 010.013
Others = breasts, skin, kidneys, heart
Table 5: Relation of blood glucose control to smear positivity for afb in ptb diabetics
p = 0.178
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Table 6: Relation of blood glucose control to different variables in diabetic patients
Variables
Uncontrolled (high)
blood glucose (26)
No. (%)
Controlled blood
glucose (9)
No. (%)
p value
Duration of hospital stay 30 ± 15 days,
range 10-80
26 ± 14 days,
range 12-72
0.55
0.65
0.61
0.58
8 (88%)
1 (12%)2 (7%)
23 (89%) 9 (100%)
2 (7%) 0(0%)
1 (4%) 0(0%)
1 (4%) 0(0%)
25 (96%) 9 (100%)
24 (93%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
2
3
No. of admissions
MDR-TB
Yes
No
Inhospital mortality
Yes
No
Several studies reported strong association
between DM and smear positive PTB 9,13,16
but that was not seen in our study as the
difference was not great to be of statistical
significance although lh of DM patients
were positive for AFB compared to about
1/3 of non-diabetic patients. This finding
was similar to findings in other studies. 6,17
Although there is evidence that DM patients
with TB have worse TB outcome than those
without DM, 16,18 this was not shown in the
number of relapses in our study, which had
no relation to the presence of DM, and it
was consistent with other reports. 7
MDR-TB was 4% in our study, that was
lower than that reported previously in
Jeddah (5.1% and 20.7%) 19,20 and there was
no relation between the presence of DM and
MDR-TB. A finding that was consistent
with previous reports 6,7 and one from Saudi
Arabia.'!
Inhospital mortality showed a difference
between diabetics and non diabetics (9% vs
3%) in our study but the statistical value
was not significant, probably because the
number of mortalities was small and
hindered reaching to significant conclusions.
Most of the DM patients had uncontrolled
blood glucose levels and had significantly
more PTB than those with controlled blood
glucose. The reason probably is the adverse
effect of PTB on glycemic control that
improves with antituberculosis treatment.st
Another explanation is that poorly
controlled glucose level is usually
considered to be the main factor causing
increased susceptibility to infections. 22 It is
well known that DM is associated with an
increased risk of TB with an overall
increased risk around 1.5 to 8 times higher
than the normal population." This is why
both these diseases are considered to be bad
companions. In our study, high blood
glucose had no relation to smear positivity
for AFB, to duration of hospital stay nor to
the outcome of these patients. Probably a
bigger number of patients may have yielded
a positive result than shown here. We
conclude that Saudi diabetic patients are
more affected with TB, but there is no
difference in the outcome between diabetic
and non-diabetic patients with TB. Since
both diseases are highly prevalent in our
community and influence each other, we
recommend that more strict measure to be
carried out to combat the spread of TB and
tightly control DM. Active case finding is
recommended by performing chest x-rays
routinely for all diabetic patients at
diagnosis and whenever they develop
unexplained deterioration of health. Latent
PTB cases should be offered
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chemoprophylaxis. We also recommend to
consider having combined clinics for both
diseases for better follow up of patients. It
would be interesting to do a prospective
study in diabetic patients with TB in
different regions of Saudi Arabia to see the
trend of clinical presentations and outcome
and would be better to include larger
number of patients than our current study
to reach to more significant results.
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